BENTONVILLE, Ark.— Soon it will be much easier and more convenient to buy GlucoDown at Walmart. Beginning this month, in-store availability of GlucoDown Diabetic Friendly Peach Tea Mix is expanding to more than 2000 Walmart pharmacies for 2021 – more GlucoDown at more Walmart pharmacies nationwide than ever before. Walmart has stocked GlucoDown Diabetic Friendly Peach
PITTSBURGH— Mylan N.V. and Biocon Biologics India Ltd., a subsidiary of Biocon Ltd., announced on Monday the U.S. launch of Semglee (insulin glargine injection) in vial and pre-filled pen presentations, approved to help control high blood sugar in adult and pediatric patients with type 1 diabetes and adults with type 2 diabetes. It is not
ALEXANDRIA, Va. – Humana, Pfizer and Walgreens are collaborating with the Pharmacy Quality Alliance (PQA) to evaluate the impact of pharmacist-provided care on medication use, health and economic outcomes in patients with diabetes. The project brings together national leaders in pharmacy, care delivery, medications, and health plan administration to demonstrate the value of collaboration between
A race is under way among pharmaceutical companies to develop drugs that treat a spectrum of liver diseases, including nonalcoholic fatty liver disease (NAFLD), an asymptomatic condition characterized by elevated levels of fat in the liver, and its more severe form, nonalcoholic steatohepatitis (NASH). The main risk factors for fatty liver disease include a sedentary
Adults with diabetes have a two- to three-times increased risk of early death compared to individuals without diabetes. Leaving diabetes uncontrolled can damage the kidneys, eyes, nerves and heart. Our new study published in JAMA Internal Medicine found that less than one in four American adults diagnosed with diabetes reach the care targets recommended by
Pharmacy accounts for the vast majority of chain drug store sales, and diabetes care is among the larger contributors to pharmacy volume. But the category is not without challenges. Most recently, insulin price inflation has raised a barrier to the purchase of — and adherence to — this life-saving prescription. The issue led Democratic and
The American Liver Foundation estimates that over 30% of the U.S. population has some degree of nonalcoholic fatty liver disease (NAFLD), the most common type of liver disease in the Western world. This can impact other facets of their overall health, because NAFLD has been linked to diabetes, obesity, insulin resistance and other metabolic risk
Last month, one furloughed government worker made national headlines by saying she had to ration her insulin because she couldn’t afford her co-pay, nor the ER bill, during the government shutdown. Recalling a day where her blood sugar was high, she admitted, “I just went to bed and hoped I’d wake up.” This is not
NEW YORK — The pharmacist plays an essential role in the continuum of care for many patients and is central to health care. While many patients might not realize it, a visit to the pharmacy is likely their most frequent opportunity to interact with a health care professional. Pharmacists are the most accessible health care
ARLINGTON, Va. – A National Association of Chain Drug Stores ) op-ed published by Morning Consult today describes the role of community pharmacy practice and of NACDS members’ philanthropic initiatives in helping to prevent and manage diabetes. “Two of the central areas where pharmacies and pharmacists have the greatest impact in diabetes are medication management and behavior change
ORLANDO, Fla. — Eli Lilly’s ultra rapid lispro (URLi) led to improved and sustained blood sugar control after meals in people with type 1 and type 2 diabetes, according to results from three phase 1b studies evaluating URLi compared to Humalog. URLi is Lilly’s novel mealtime insulin currently in phase 3 development. The data was presented in
RIDGEFIELD, Conn. and INDIANAPOLIS — Boehringer Ingelheim and Eli Lilly and Co. yesterday announced an academic collaboration with the University of Oxford to investigate the effects of Jardiance on the progression of kidney disease and the occurrence of cardiovascular death, in adults with established chronic kidney disease with and without diabetes. EMPA-KIDNEY will be independently conducted, analyzed and reported by the Medical
BRIDGEWATER, N.J. — Sanofi’s new Insulins VALyou Savings Program will seek to help lower out-of-pocket costs for people living with diabetes who otherwise would pay full retail price for Lantus or Admelog. This includes certain uninsured patients who don’t qualify for traditional patient assistance programs, in addition to some commercially insured patients with a high
WEST DES MOINES, Iowa — Midwestern retailer Hy-Vee is enhancing its diabetes programs with Begin for Diabetes, a lifestyle management program designed for the unique set of health and nutrition challenges those dealing with the disease face. The program, which the company just launched, adds to Hy-Vee’s existing Begin and Begin 4 Kids programs. All three diabetes